Skip to Content
 

E-Newsletter

  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent

    Archives

    Join Us

    News: Cancer Research

    VICC leads study on high breast cancer incidence and mortality rates in African-American women

    Wednesday, July 6th, 2016

    A cancer research consortium headed by investigators at Vanderbilt-Ingram Cancer Center (VICC) and two other institutions, today received $12 million in federal funding to help determine why African-American women die at a higher rate and have more aggressive breast cancer than white women.  The grant, which was awarded by the National Cancer Institute (NCI), part […]

    Superior scan for tumors

    Friday, June 24th, 2016

    While relatively rare, tumors of neuroendocrine cells, which release hormones in response to neuronal signals, have been difficult to diagnose and treat. Now Ronald C. Walker, M.D., and colleagues have reported that PET/CT imaging using the radionuclide Gallium-68 combined with DOTATATE, a compound that binds to these types of tumor cells, is safe and clearly […]

    Lovly tapped to brief Congress on cancer research

    Thursday, June 23rd, 2016

    Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology, has been selected to testify before members of Congress about the importance of cancer research, including early training programs for individuals interested in science. The Congressional briefing will be held Tuesday, June 28, on Capitol Hill in Washington, D.C. The event, organized by the […]

    VU takes key role in cancer drug discovery consortium

    Thursday, June 23rd, 2016

    Vanderbilt University has been selected as one of seven Dedicated Centers in the nation for the next phase of the Chemical Biology Consortium (CBC), a national network of scientists on the leading edge of cancer drug discovery. Vanderbilt has been part of the CBC since the consortium was established in 2009 as the discovery engine […]

    New software tracks cancer mutations, survival

    Thursday, June 2nd, 2016

    Malignant tumors are increasingly subject to routine clinical genotyping, primarily to predict drug response or assist with prognosis. A team at Vanderbilt University Medical Center (VUMC) has developed and tested software that scans electronic health records in real time to monitor cancer patient survival (from time of diagnosis) according to which genes, if any, are […]

    Precision medicine already changing cancer treatment strategies

    Thursday, May 26th, 2016

    The ability to test patients’ cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment. “Nationwide we’re seeing great promise with this approach […]

    Students’ cancer research efforts land honors

    Thursday, May 19th, 2016

    Two Vanderbilt students were recognized for their contributions to cancer research during the Vanderbilt-Ingram Cancer Center (VICC) Annual Scientific Retreat held May 6 at the Vanderbilt University Student Life Center. Huzefa Dungrawala, Ph.D., was named VICC Postdoctoral Student of the Year for his outstanding research in the laboratory of David Cortez, Ph.D., Ingram Professor of […]

    VICC investigators in spotlight at AACR conference

    Thursday, May 19th, 2016

    A top Vanderbilt-Ingram Cancer Center (VICC) investigator recently met with Vice President Joe Biden regarding the National Cancer Moonshot Initiative, a major national program to identify, fund and accelerate the most promising research leading to cancer cures. Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies and the VICC Breast Cancer Program, […]

    Endowed fellowships help create personal connections

    Monday, May 16th, 2016

    When former Nashvillian Carol O’Hare speaks about a specific group of physicians at Vanderbilt-Ingram Cancer Center (VICC), her voice softens, and she refers to them affectionately as “my fellows.” O’Hare, a 19-year cancer survivor who received life-saving treatment at VICC and whose late husband was also treated for cancer here, decided to support oncology research […]

    Improving natural killer cancer therapy

    Friday, May 6th, 2016

    Natural Killer (NK) cells are a type of white blood cell that specifically recognize and destroy tumor cells. For this reason, NK cell transfer therapy is a promising cancer treatment. Expansion and persistence of donor NK cells correlates with tumor clearance, suggesting that therapeutic efficacy can be enhanced by augmenting NK cell survival. Now, Whitney […]

    Next Page »« Previous Page

    E-Newsletter

  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent

    Archives

    Join Us